Brief: Eastgate Biotech Receives Regulatory Approval To Initiate A Phase III 90-Day Clinical Trial On Insugin, Its Liquid Insulin Mouth Rinse Solution25/09/2019 14:19
Last trade - 00:00Last trade - 00:00Last trade - 00:00